LOGIN  |  REGISTER

LevelJump Healthcare Announces Receipt of Notice of Requisition for a Meeting of Shareholders

November 07, 2025 | Last Trade: C$0.07 0.005 -7.14

Toronto, Ontario--(Newsfile Corp. - November 7, 2025) - LevelJump Healthcare Corp. (TSXV: JUMP) ("LevelJump" or the "Company") announces that a notice of requisition of a meeting of shareholders (the "Requisition") was delivered to the registered office of the Company on November 3, 2025.

The Requisition has been made by Frank Teti and Franmar Properties Ltd. (collectively the "Concerned Shareholders") which requires that the Company call and hold a meeting of shareholders pursuant to section 105(1) of the Business Corporations Act (Ontario) (the "Act"). The purpose of the proposed meeting is to: (i) pass an ordinary resolution to remove all five (5) incumbent directors from the Board; and (ii) to elect Claude Ayache, Rob Saltsman, Jeff Stevens, Sheldon Levy, and Tasheel Jeerh as director nominees replacing the incumbent directors.

The Company is reviewing the Requisition and will respond within the time required by the Act.

About LevelJump Healthcare

LevelJump Healthcare Corp., (TSXV: JUMP) provides telehealth solutions to client hospitals and imaging centers through its Teleradiology division, as well as in person radiology services through its Diagnostic Centres. JUMP focuses primarily on critical care for urgent and emergency patients, establishing integral relationships in the communities we serve.

ON BEHALF OF THE BOARD OF DIRECTORS OF
LEVELJUMP HEALTHCARE CORP.

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION

This news release contains "forward-looking information" within the meaning of applicable securities laws relating to the Company's business plans and the outlook of the Company's industry. Although the Company believes, in light of the experience of its officers and directors, current conditions and expected future developments and other factors that have been considered appropriate, that the expectations reflected in this forward-looking information are reasonable, undue reliance should not be placed on them because the Company can give no assurance that they will prove to be correct. Actual results and developments may differ materially from those contemplated by these statements. The statements in this press release are made as of the date of this release and the Company assumes no responsibility to update them or revise them to reflect new events or circumstances other than as required by applicable securities laws. The Company undertakes no obligation to comment on analyses, expectations or statements made by third-parties in respect of the Company, Canadian Teleradiology Services, Inc., their securities, or their respective financial or operating results (as applicable).

Neither the Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Exchange) accepts responsibility for the adequacy or accuracy of this release.

Viking Therapeutics

Stock Quote

Featured Stock

Cue Biopharma

Cue Biopharma is developing the first-ever class of therapeutics for the treatment of cancer that mimic the natural signals, or “Cues”, of the immune system. This novel class of injectable biologics selectively engages and modulates tumor-specific T cells directly within the patient’s body to transform...

CLICK TO LEARN MORE

Featured Stock

Chimerix

Chimerix is on a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The company is devoted to filling gaps in the treatment paradigm. Chimerix’s most advanced clinical-stage program is in development for H3 K27M-mutant glioma....

CLICK TO LEARN MORE

End of content

No more pages to load

Next page